myocardial-infarction

Documents about myocardial-infarction

• Platelet GARP-dependent activation of TGF-β1 limits inflammation and promotes cardiac repair after myocardial infarction#426538bioRxiv / medRxiv
• Adipocytokine Pathway Dysregulation Characterizes Immune-Related Molecular Subtypes and Candidate Biomarkers in Myocardial Infarction.#427659NCBI PubMed Central
• Biomimetic oriented nanofiber-reinforced conductive cardiac patch for enhanced cardiac repair after myocardial infarction.#469233NCBI PubMed Central
• Detection of myocardial infarction by postmortem CT combined with radiomics-based machine-learning analysis.#785579NCBI PubMed Central
• DCB Under the Guidance of OCT in STEMI#830236ClinicalTrials.gov
• The Effect of 12 Lead ECG Telemetry on Reperfusion Time in Resource-limited Settings#834155ClinicalTrials.gov
• Prehospital Risk Stratification in Acute Coronary Syndromes#836706ClinicalTrials.gov
• SIDAMI - Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (AMI)#837990ClinicalTrials.gov
• Identify Clinical Conditions That Increase Circulating DNA Levels#845714ClinicalTrials.gov
• RUral dispaRities in prehospitAL STEMI#847927ClinicalTrials.gov
• Determining the Effect of Abacavir on Platelet Activation#851985ClinicalTrials.gov
• Predictive Value of PRECISE DAPT Score in STEMI Patients After Primary PCI#853070ClinicalTrials.gov
• Echocardiographic Examination Performed by Nurses in Cardiac Intensive Care Unit#856347ClinicalTrials.gov
• The SORT OUT IX STEMI OCT Trial#871452ClinicalTrials.gov
• Minnesota Heart Survey - Mortality and Morbidity#879363ClinicalTrials.gov
• Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock#881624ClinicalTrials.gov
• Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation#893274ClinicalTrials.gov
• Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction#894022ClinicalTrials.gov
• Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients#900859ClinicalTrials.gov
• Effect of Shexiang Tongxin Dropping Pills on Microcirculation in Patients With AMI#909016ClinicalTrials.gov
• ECG-guided Immediate Primary PCI for Culprit Vessel to Reduce Door to Device Time#911824ClinicalTrials.gov
• Triggers of Ventricular Arrhythmias (TOVA) Study#915197ClinicalTrials.gov
• The usefulness of cardiac magnetic resonance in prevention of sudden cardiac death after myocardial infarction: Author's reply#934667Koc University Digital Collections
• Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction#968474ClinicalTrials.gov
• Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock#982503ClinicalTrials.gov
• Cohort of STEMI Patients 2#1008828ClinicalTrials.gov
• A Study of VentriGel in Post-MI Patients#1010633ClinicalTrials.gov
• Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction#1032292ClinicalTrials.gov
• ARISE - Aggressive Reduction of Inflammation Stops Events#1032985ClinicalTrials.gov
• Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI#801015ClinicalTrials.gov
• The Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Myocardial Infarction#845296ClinicalTrials.gov
• Switching From Cardiac Troponin I to T#863172ClinicalTrials.gov
• A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction#890780ClinicalTrials.gov
• Genetic Mapping for Cardiac Risk Assessment#894387ClinicalTrials.gov
• Microvascular Recovery With Ultrasound in Myocardial Infarction (MRUSMI) Post PCI Trial#911464ClinicalTrials.gov
• Cardioprotective mechanisms against reperfusion injury in acute myocardial infarction: targeting angiotensin II receptors#250639IRIS
• 3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions#859089ClinicalTrials.gov
• Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial#883064ClinicalTrials.gov
• Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI#917918ClinicalTrials.gov
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes#6883OpenAlex
• Contribution of Cardiac CD34⁺ Stromal Cells to Post-Myocardial Infarction Repair in Middle-Aged Rats.#9179NCBI PubMed Central
• T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events#127743ClinicalTrials.gov
• Neighborhood characteristics and incident myocardial infarction in US older adults: evaluation in 2 nationwide cohorts.#143420NCBI PubMed Central
• 3D cardiac shape analysis with variational point cloud autoencoders for myocardial infarction prediction and virtual heart synthesis#155945PMC Full-Text (OAI)
• A Novel ApoB/ApoA1 Ratio-Integrated Nomogram to Predict Cardiogenic Shock After Acute Myocardial Infarction.#170640NCBI PubMed Central
• Dynamical Predictive Modelling of Cardiovascular Disease Progression Post-Myocardial Infarction via ECG-Trained Artificial Intelligence Model#180708arXiv CS
• Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes#245419ClinicalTrials.gov
• Sex-Consistent Performance of an AI-Enabled ECG for Acute Myocardial Infarction: The ROMIAE Study.#320498NCBI PubMed Central
• Organ-Specific Efficacy of Postischemic Empagliflozin in Acute Stroke and Myocardial Infarction Using Preclinical Models.#326967NCBI PubMed Central
• Different forms of cardiomyocyte death in post-myocardial infarction ventricular remodeling: mechanisms and therapeutic strategies.#354656NCBI PubMed Central